Michael Virata
Impact in
- Health top 10%
- Vaccine Coverage and Hesitancy
-
- Antimicrobial Resistance in Staphylococcus
- HIV/AIDS Research and Interventions
Papers in
-
- Hepatitis C virus research 2
-
- HIV/AIDS Research and Interventions 2
- Co-authors
- Catherine J. Hardalo (1 shared paper)Fredrick L. Altice (1 shared paper)G. Friedland (1 shared paper)Lydia Barakat (7 shared papers)Sheela Shenoi (4 shared papers)Jaimie P. Meyer (3 shared papers)Roman Shrestha (2 shared papers)Jeffrey A. Wickersham (2 shared papers)
- Journals
- Clinical Infectious Diseases (4 papers)F1000Research (2 papers)AIDS and Behavior (2 papers)Journal of Substance Abuse Treatment (1 paper)Frontiers in Medicine (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Michael Virata
21 papers receiving 316 citations
Peers
Comparison fields: 5 of 46
- Health 46
- Infectious Diseases 78
- Epidemiology 107
- Virology 12
- Microbiology 17
Countries citing papers authored by Michael Virata
This map shows the geographic impact of Michael Virata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Virata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Virata more than expected).
Fields of papers citing papers by Michael Virata
This network shows the impact of papers produced by Michael Virata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Virata. The network helps show where Michael Virata may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Virata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 84 | |
| 2 | 2015 | 51 | |
| 3 | 1996 | 33 | |
| 4 | 2022 | 33 | |
| 5 | 2018 | 27 | |
| 6 | 2024 | 21 | |
| 7 | Prevalence of Metabolic Syndrome in Patients with HIV in the Era of Highly Active Antiretroviral Therapy. | 2015 | 16 |
| 8 | 2022 | 16 | |
| 9 | 1998 | 13 | |
| 10 | 2020 | 10 | |
| 11 | 2023 | 6 | |
| 12 | 2021 | 5 | |
| 13 | 2011 | 3 | |
| 14 | 2022 | 3 | |
| 15 | 2018 | 2 | |
| 16 | 2023 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2017 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2024 | 1 |
About Michael Virata
Michael Virata is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Health and Geriatrics and Gerontology, having authored 21 papers that have together received 331 indexed citations. Recurring topics across this work include Substance Abuse Treatment and Outcomes (3 papers), HIV, Drug Use, Sexual Risk (2 papers), Hepatitis C virus research (2 papers), HIV/AIDS Research and Interventions (2 papers), Vaccine Coverage and Hesitancy (2 papers), HIV-related health complications and treatments (1 paper), Data-Driven Disease Surveillance (1 paper) and Pediatric Hepatobiliary Diseases and Treatments (1 paper). The work is most often cited by research in Health (46 citations), Infectious Diseases (78 citations), Epidemiology (107 citations), Virology (12 citations) and Microbiology (17 citations). Michael Virata has collaborated with scholars based in United States and China. Frequent co-authors include Catherine J. Hardalo, Fredrick L. Altice, G. Friedland, Lydia Barakat, Sheela Shenoi, Jaimie P. Meyer, Roman Shrestha, Jeffrey A. Wickersham, Frederick Lewis Altice and Antoine Khati. Their work appears in journals such as Clinical Infectious Diseases, F1000Research, AIDS and Behavior, Journal of Substance Abuse Treatment and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.